English 中文
About HVSEN Enterprise Culture Honors


By constructing a comprehensive value chain from R&D to manufacture of APIs and preparations, HVSEN Biotech is one of the TOP 10 animal health enterprises in China, and now has 4 factories, 2 R&D centers and 6 BUs. As the mission of “Biotech for better life”, HVSEN is committed to supply safety and innovative products and solutions to domestic & aboard markets for more than 10 years.


HVSEN is focusing on the innovation of novel macrolides APIs and preparations, with 42 patents and 3 certificated novel APIs. It has been famous of tylvalosin raw material, various tylvalosin preparations, florfenicol preparations and other macrolides products in the market for more than 10 years . Presently HVSEN has the capability of producing more than 50 veterinary drug products of raw materials & preparations, also  some traditional Chinese medicines (TCMs) extractives .

Purification patent of Tylvalosin tartrateSeed strain patent of Tylvalosin tartrateA premix for inhibition of reproduction of PRRSPreparation method of Tilmicosin pelletEnrofloxacin injection patentPreparation method of Long-term Ceftiofur hydrochloride injectionPreparation method of Danofloxacin mesylate pelletValnemulin hydrochloride premix patentPatent of Compound pre-mixed feed for swineLong-term Cefquinome sulfate injection patentSynthetic method of TulathromycinEnrofloxacin injection patentChemical synthesis method of Cefquinome sulfate